Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphofurin acidic cluster-disseminator protein 1 (PACS-1) is a cytosolic sorting protein that plays a critical role in the intracellular trafficking of various cargo proteins between the trans-Golgi network (TGN) and endosomes (UniProt P53351). It functions by recognizing and binding to acidic cluster motifs on the cytoplasmic tails of its targets, such as the proprotein convertase furin and the cation-independent mannose 6-phosphate receptor (Molecular Biology of the Cell, 2005). Beyond its physiological role in protein sorting, PACS-1 is a significant factor in viral pathogenesis; for instance, the HIV-1 Nef protein hijacks PACS-1 to downregulate MHC-I molecules, thereby allowing the virus to evade the host immune system (Journal of Biological Chemistry, 2008). Mutations in the PACS1 gene, most notably the recurrent p.Arg203Trp variant, are the primary cause of PACS1 syndrome (Schuurs-Hoeijmakers syndrome), a rare neurodevelopmental disorder characterized by intellectual disability and distinct facial features (Nature Genetics, 2012). While there are currently no FDA-approved drugs targeting PACS-1, it remains a subject of research as a potential therapeutic target for preventing viral immune evasion and managing associated genetic disorders (Frontiers in Cell and Developmental Biology, 2017).
Inhibition of PACS-1/cargo protein interactions to prevent viral immune evasion or restore cellular protein trafficking homeostasis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphofurin acidic cluster-disseminator protein 1 (PACS-1).